Brief: Pliant Therapeutics Provides Corporate Update And Reports Fourth Quarter 2023 Financial Results

Pliant Therapeutics

27/02/2024 22:02

Pliant Therapeutics Inc  PLRX.O :
    * PLIANT THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS
FOURTH
QUARTER 2023 FINANCIAL RESULTS
    * PLIANT THERAPEUTICS INC -POSITIVE INTERIM 12-WEEK SAFETY
AND
EFFICACY DATA REPORTED FROM PHASE 2A INTEGRIS-PSC TRIAL IN
PATIENTS WITH PSC
    * PLIANT THERAPEUTICS INC -ENROLLMENT CONTINUES IN
BEACON-IPF, A
PHASE 2B TRIAL IN PATIENTS WITH IPF
    * PLIANT THERAPEUTICS INC - AS OF DEC 31, 2023, CO HAD CASH,
CASH
EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $495.7 MILLION
    * PLIANT THERAPEUTICS INC - EXPECTS CASH, CASH EQUIVALENTS
AND
SHORT-TERM INVESTMENTS TO BE SUFFICIENT TO FUND OPERATIONS INTO
H2 2026

Source text for Eikon:  ID:nGNX38CwL 
Further company coverage:  PLRX.O